Article Details
Retrieved on: 2025-05-14 20:34:34
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
MOUNTAIN VIEW, Calif., May 14, 2025--Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here